Bristol-Myers Squibb Management
Management criteria checks 3/4
Bristol-Myers Squibb's CEO is Chris Boerner, appointed in Nov 2023, has a tenure of less than a year. total yearly compensation is $8.46M, comprised of 14.9% salary and 85.1% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth CHF4.15M. The average tenure of the management team and the board of directors is 2.3 years and 4.4 years respectively.
Key information
Chris Boerner
Chief executive officer
US$8.5m
Total compensation
CEO salary percentage | 14.9% |
CEO tenure | less than a year |
CEO ownership | 0.005% |
Management average tenure | 2.3yrs |
Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$6b |
Dec 31 2023 | US$8m | US$1m | US$8b |
Sep 30 2023 | n/a | n/a | US$8b |
Jun 30 2023 | n/a | n/a | US$8b |
Mar 31 2023 | n/a | n/a | US$7b |
Dec 31 2022 | US$7m | US$1m | US$6b |
Sep 30 2022 | n/a | n/a | US$7b |
Jun 30 2022 | n/a | n/a | US$7b |
Mar 31 2022 | n/a | n/a | US$6b |
Dec 31 2021 | US$7m | US$1m | US$7b |
Sep 30 2021 | n/a | n/a | -US$5b |
Jun 30 2021 | n/a | n/a | -US$5b |
Mar 31 2021 | n/a | n/a | -US$6b |
Dec 31 2020 | US$6m | US$953k | -US$9b |
Sep 30 2020 | n/a | n/a | -US$44m |
Jun 30 2020 | n/a | n/a | -US$563m |
Mar 31 2020 | n/a | n/a | US$954m |
Dec 31 2019 | US$6m | US$891k | US$3b |
Compensation vs Market: Chris's total compensation ($USD8.46M) is about average for companies of similar size in the Swiss market ($USD7.02M).
Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.
CEO
Chris Boerner (52 yo)
less than a year
Tenure
US$8,461,833
Compensation
Dr. Christopher S. Boerner, also known as Chris, Ph.D. served as Chief Operating Officer at Bristol-Myers Squibb Company since April 26, 2023 to 2023 and served as its Executive Vice President since April...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | less than a year | US$8.46m | 0.0050% $ 4.1m | |
Executive VP & CFO | 4.4yrs | US$7.17m | 0.0096% $ 8.0m | |
Executive VP & General Counsel | 17.2yrs | US$5.92m | 0.022% $ 18.4m | |
Executive VP | 4.8yrs | US$6.23m | 0.0030% $ 2.5m | |
Executive VP and Chief Digital & Technology Officer | 2.3yrs | no data | 0.00026% $ 216.0k | |
VP & Head of Investor Relations | no data | no data | no data | |
Chief Compliance & Ethics Officer | less than a year | no data | no data | |
Executive Vice President & Chief Human Resources Officer | less than a year | no data | 0.00013% $ 108.0k | |
Head of Medical Affairs | no data | no data | no data | |
Executive VP | no data | no data | 0.00080% $ 664.7k | |
Senior Vice President of Major Markets | no data | no data | no data | |
Executive Vice President of Global Product Development & Supply | 2.3yrs | no data | 0.00030% $ 249.2k |
2.3yrs
Average Tenure
53yo
Average Age
Experienced Management: BMY's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 1.3yrs | US$8.46m | 0.0050% $ 4.1m | |
Independent Director | 12.3yrs | US$357.50k | 0% $ 0 | |
Independent Director | 3.6yrs | US$375.00k | 0% $ 0 | |
Independent Director | 4.4yrs | US$365.00k | 0% $ 0 | |
Independent Director | 8yrs | US$359.68k | 0% $ 0 | |
Independent Director | 1.8yrs | US$329.97k | 0% $ 0 | |
Lead Independent Director | 7.2yrs | US$425.00k | 0.0018% $ 1.5m | |
Independent Director | 3.6yrs | US$365.00k | 0% $ 0 | |
Independent Director | 4.4yrs | US$371.68k | 0.00067% $ 556.6k | |
Independent Director | 6.3yrs | US$344.74k | 0% $ 0 | |
Independent Director | 2.8yrs | US$335.00k | 0% $ 0 |
4.4yrs
Average Tenure
62yo
Average Age
Experienced Board: BMY's board of directors are considered experienced (4.4 years average tenure).